Syra Health (SYRA) CEO Gregory Receives 368,458 Performance Stock Units

What Happened

• Alexander Gregory R., CEO of Syra Health Corp (SYRA), was granted 368,458 performance-based equity units on 2026-08-11. The award is recorded as a derivative grant at an acquisition price of $0.00 (i.e., a stock award/PSU, not a cash purchase).
• The filing does not report a cash value or the post-transaction total shares owned in this Form 4; these units vest over time and/or upon performance, so they are not immediately transferable shares.

Key Details

• Transaction date: 2026-08-11; Form 4 filed 2026-08-14 (no late-filing flag noted in the provided data).
• Security: 368,458 performance stock units (derivative award) at $0.00.
• Vesting: Footnote — 20% of the PSUs vest one year after grant; the remainder vests only upon achievement of specified company financial metrics.
• Shares owned after transaction: not specified in the provided filing.
• Transaction type code: A (award/grant).

Context

• This is an equity award (performance stock units), not a market purchase or sale. Such awards are commonly used for executive compensation and align pay with company performance; they only convert to actual shares or value if vesting/time and/or performance conditions are met.
• For retail investors, awards signal retention and incentive alignment rather than immediate insider buying/selling.